House Investigation Of Tainted Heparin Could Highlight Need For Import Safety Legislation - Or Not
This article was originally published in The Pink Sheet Daily
Executive Summary
Energy and Commerce Republicans seek to determine who contaminated heparin supplies in 2008, how they did it, and why FDA has failed to answer those questions as the panel begins oversight of the agency.
You may also be interested in...
FDA Drug Shortage Strategy: Heparin Is Test Case For Developing Alternate Sources
Science board encourages agency to address broader economic shortage causes.
FDA Foreign Inspections User Fee Program Getting Push On The Hill
The pharmaceutical industry faces an increasingly aggressive push to create user fees for manufacturing inspections.
FDA Foreign Inspections User Fee Program Getting Push On The Hill
The pharmaceutical industry faces an increasingly aggressive push to create user fees for manufacturing inspections.